✦ LIBER ✦

Alternative temozolomide dosing regimens and novel combinations for the treatment of advanced metastatic melanoma

✍ Scribed by Wen-Jen Hwu; Ana E. Ayala; Ingrid M. Hernandez

Book ID: 107615962
Publisher: PAGEPress Publications
Year: 2008
Tongue: English
Weight: 104 KB
Volume: 2
Category: Article
ISSN: 1970-5557
DOI: 10.1007/s12156-008-0073-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A novel immunoregulatory regimen combini

A novel immunoregulatory regimen combining high dose interleukin-2 and taurolidine for the treatment of patients with progressive metastatic melanoma

✍ G. C. O’Brien; R. A. Cahill; M. J. O’Sullivan; D. J. Bouchier-Hayes; H. P. Redmo 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 242 KB

Temozolomide is a novel regional infusio

Temozolomide is a novel regional infusion agent for the treatment of advanced extremity melanoma

✍ Tomio Ueno; Sae Hee Ko; Elizabeth Grubbs; Scott K. Pruitt; Henry S. Friedman; Do 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 122 KB

224 Comparison of efficacy two different

224 Comparison of efficacy two different dose DTIC-based chemotherapy regimens and two non-DTIC based regimens in the treatment of metastatic malignant melanoma; study in 159 patients

✍ V. Kovčin; S. Jelić; L. Mitrović; S. Radulović; Z. Tomašević; N. Milanovtć; N. B 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Development of ipilimumab: a novel immun

Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma

✍ Wolchok, Jedd D.; Hodi, F. Stephen; Weber, Jeffrey S.; Allison, James P.; Urba, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 733 KB

Novel Immunotherapeutic Agents and Small

Novel Immunotherapeutic Agents and Small Molecule Antagonists of Signalling Kinases for the Treatment of Metastatic Melanoma

✍ Nagendra Natarajan, Sucheta Telang, Donald Miller, Associate Professor Jason Che 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 270 KB

Pilot study of continuous low-dose 5-flu

Pilot study of continuous low-dose 5-fluorouracil and cisplatin (FP regimen) for the treatment of metastatic breast cancer

✍ Y. Yamada; K. Aiba; N. Horikosi; M. Hanai; S. Uno; H. Osawa; N. Mizunuma; S. Tak 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 59 KB